Drugs / NGX426
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00832546 | May → Sep 2008 | — | TorreyPines Therapeutics | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NGX426 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00832546 ↗ |
| Action | Inhibit | “Glutamate receptor ionotropic kainate 1 antagonist” CHEMBL2103869 ↗ |
| Modality | Small molecule | — CHEMBL2103869 ↗ |
| Route | Oral | “Oral NGX426 (Powder in solution)” NCT00832546 ↗ |
| Target | GRIK1 | “Glutamate receptor ionotropic kainate 1 antagonist” CHEMBL2103869 ↗ |